Objectives. Peptidoglycan (PG), a component of Gram-positive bacteria, may be involved in rheumatoid arthritis (RA) because of its ability to induce production of proin¯ammatory cytokines, to induce arthritis in rodents, and its presence in antigen-presenting cells in RA joints.
Rheumatoid arthritis (RA) is a chronic in¯ammatory disease with unknown aetiology. For many years, the most attractive concept of the pathogenesis of RA has been the model of autoimmunity, in which autoreactive T cells play an important role. The association of susceptibility to RA and disease outcome with HLADR4uDR1 antigens w1, 2x has been regarded as the strongest argument for the T-cell-dependent nature of the disease. Moreover, T cells present in the in¯amed joints consist predominantly of the primed CD45RO subset, expressing early and late activation antigens w3±5x. The importance of interactions between T cells and antigen-presenting cells (APC), as shown by the expression of CD40L, CD28 and CTLA4 by T cells and of B7-1 (CD80), B7-2 (CD86) and CD40 by APC in the synovium, has also focused attention on the role of APC in RA w6±10x. A crucial role of APC in the pathogenesis of RA is suggested by the high levels of expression and production of the proin¯ammatory cytokines interleukin 1b (IL-1b), interleukin 6 (IL-6) and tumour necrosis factor a (TNF-a), produced by monocytesumacrophages, which affect ®broblasts, chondrocytes and lymphocytes in the blood, synovial uid and synovial tissue of RA patients w6 ±11x. This is supported by the promising results with anti-TNF-a or anti-TNF receptor therapies in RA patients w12x and the development of spontaneous arthritis in TNF-a mice w13, 14x. Furthermore, the matrix metalloproteinase gelatinase B, the expression of which is regulated by cytokines and other in¯ammatory mediators, has been detected in the synovial¯uid of RA patients w15x.
The (auto)antigen(s) leading to chronic stimulation of T cells anduor macrophages are still unknown. In reactive arthritis, the triggering antigens are thought to be microbes that cause infections of the urogenital tract and the gut, such as Chlamydia trachomatis, Yersinia and Salmonella species w16, 17x. Antigens of these bacteria have been detected in synovial cells w18±20x, and T cells speci®c for these antigens have been found in the synovium w21, 22x. Because RA is a chronic disease, it may be that the bacterial load in the intestine, with which we are in lifelong close contact, is important in the induction and perpetuation of RA. This is supported by the observation that some patients with Crohn's disease and ulcerative colitis, both of which are intestinal autoimmune diseases, may suffer from arthritis w23, 24x. We and others have hypothesized previously that peptidoglycan (PG) plays a role in the pathogenesis of RA w25±28x. PG is the major component of the cell wall of Gram-positive bacteria and is composed of long sugar chains of alternating N-acetyl glucosamine and N-acetyl muramic acid residues, which are interlinked by peptide bridges, resulting in a large complex macromolecular structure w29x. PG isolated from the anaerobic bacterium Eubacterium aerofaciens, which is present in numbers over 10 9 ug human faeces, induces severe and chronic arthritis in rats w30x.
Furthermore, PG could be detected in APC in synovial tissues of RA patients by the use of a speci®c antibody w31, 32x. PG has also been isolated from sterile normal human spleen using biochemical methods (PG spleen ) w33, 34x. In vitro analysis showed that the latter PG fraction is able to induce production of the proin¯ammatory cytokines TNF-a, IL-1 and IL-6 w34x, which are crucially involved in the pathogenesis of RA w11x. Furthermore, it has been shown that PG isolated from human spleen is able to bind to the CD14 receptor and to elicit T-cell proliferation of CD4-and CD8-positive abTCR T cells after proteolytic processing (I.A. Schrijver et al., submitted for publication). Previously, T-cell responses against peptidoglycan± polysaccharide complexes (PG-PS faeces ) isolated from human faeces have been analysed in peripheral blood and synovial¯uid of RA patients. In this report, only low responses to PG were found w35x. In the present study we used PG spleen because it re¯ects the properties of PG present in human tissues, it is structurally more intact than PG-PS faeces and it has a 10-to 100-fold greater biological activity w34x.
To further delineate the role of PG in the pathogenesis of RA, we determined the in¯uence of PG fractionated from sterile human spleen on T-cell proliferation and the production of in¯ammatory mediators. Therefore, we determined the production of the proin¯ammatory cytokines IL-1b, IL-6, interferon c (IFN-c) and TNF-a, the immunoregulatory cytokine IL-10, the chemokine IL-8 and the matrix metalloproteinase gelatinase B in peripheral blood of RA patients and control subjects and in synovial¯uid samples from RA patients after stimulation with PG.
Patients and methods

Patients
Blood samples. Heparin blood samples of 29 RA patients ful®lling the American College of Rheumatology criteria w36x were obtained from the Zuiderziekenhuis Hospital Rotterdam. Patients received no immunosuppressive medication except for ®ve patients receiving low-dose prednisone (up to 10 mguday) or methotrexate (up to 30 mguweek). RA disease activity at the time of blood sampling was determined using the disease activity score by an experienced rheumatologist w37x. This was calculated with the formula 0.56 !TJC + 0.28 !SJC + 0.7 log ESR + 0.014 GH, where TJC is the number of painful joints (out of 28), SJC is the number of swollen joints (out of 28) and GH is the general health score on a visual analogue scale (0±100). Twenty-seven blood samples of healthy donors were a kind gift from the Department of Epidemiology of the University Hospital of Rotterdam. Ten blood samples were obtained from healthy volunteers. Characteristics of the donors of blood samples are shown in Table 1 . All blood samples were processed within 2±5 h after collection.
Synovial¯uid samples. Synovial¯uid samples of an in¯amed joint of 14 RA patients were obtained from the Zuiderziekenhuis in Rotterdam (Table 1) . Synovial uid was collected in heparin tubes. Paired blood and synovial¯uid samples were collected from 10 of these patients.
Proliferation assays
Peripheral blood mononuclear cells (PBMC) of all healthy donors and RA patients and synovial¯uid mononuclear cells (SFMC) of 14 RA patients were isolated from heparinized blood using Ficoll Hypaque (Pharmacia, Uppsala, Sweden). Cells (2 3 10 5 cells in 100 ml) were cultured in 96-well plates in the presence of 100 ml PG isolated from human spleen containing 0.70 mg muramic acid w34x, PG-PS faeces containing 70 mguml muramic acid w38x, 2 mguml lipopolysaccharide (LPS) (Sigma, St Louis, MO, USA) or 6 Lfuml tetanus toxoid (TT) as a control recall protein antigen (RIVM, Bilthoven, The Netherlands). Cells and antigens were diluted in RPMI (Biowittaker, Verviers, Belgium) + 10% heat-inactivated human serum. All antigens were analysed in triplicate and concentrations given in the Results section are ®nal concentrations. The cells were cultured for 7 days, the last 8 h in the presence of tritiated thymidine (Amersham, Pharmacia Biotech, Little Chalfont, UK). The cells were then harvested and the incorporated radioactivity was counted in a liquid scintillation counter. The proliferative response was expressed as counts per minute (c.p.m.) or stimulation index (SI), the ratio of mean c.p.m. in the presence and absence of antigen. When SI > 3, it was concluded that proliferation had occurred.
Induction of cytokine release in whole blood, whole synovial¯uid, PBMC or SFMC after stimulation with PG Cytokine induction was performed in 20 blood and nine synovial¯uid samples of RA patients and in six to 10 healthy control blood samples using a method described before w34x. RPMI 1640 (Biowittaker) w12 ml, containing 90 nguml PG (muramic acid) or 25 nguml LPS (Sigma)x was added to a polypropylene tube containing 11.25 ml blood, synovial¯uid, PBMC or SFMC. The mixtures were incubated for 4 or 17 h at 378C in a 5% carbon dioxide atmosphere. Then 375 ml RPMI was added to each tube and the mixtures were centrifuged for 10 min at 400 g. The supernatants were stored at 2 208C until analysis for cytokines and gelatinase B.
Determination of cytokines
Cytokine production was measured by commercial capture ELISA. In a pilot study of 10 healthy donors, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12p40, TNF-a, IFN-c and GM-CSF were measured in culture supernatants of 4-and 17-h supernatants. IL-4 and GM-CSF were undetectable in the supernatants. After LPS stimulation, IL-1b, IL-6, IL-10, IL-12 and TNF-a reached their highest levels after 4 h of stimulation and IL-8 and IFN-c after 17 h. Therefore IL-1b, IL-6, IL-10, IL-12p40 and TNF-a production was measured in the 4-h supernatants and IL-8 and IFN-c in the 17-h supernatants. ELISA was performed according to the manufacturer's guidelines (Biosource, Fleurus, Belgium). Brie¯y, polystyrene microtitre wells (Immuno Maxisorp; Nunc, Roskilde, Denmark) were coated overnight at room temperature with monoclonal anti-cytokine antibodies followed by washing (0.9% NaCl) and 2 h of blocking (phosphate-buffered salineubovine serum albumin 0.5%). Freshly thawed supernatants of the cell cultures and recombinant human cytokine standards were incubated in duplicate for 2 h in the presence of a biotinylated second anti-cytokine antibody, followed by washing steps, poly-streptavidin±horseradish peroxidase (CLB, Amsterdam, The Netherlands) and enzyme substrate (TMB peroxidase; KPL, Gaithersburg, MD, USA). Optical density was measured at 450 nm.
Determination of gelatinase B activity
Gelatinase B (MMP-9) was measured by two methods in the supernatants obtained after 4 h of stimulation. First, the quantitative gelatine zymography method was used. This is a densitrometric method that, by inclusion of appropriate standards, discriminates inducible gelatinase B (MMP-9) from constitutive gelatinase A w15, 39x. Quantitative determination of gelatinase activity was achieved by computerized image analysis using two-dimensional scanning densitometry. Gelatinase activity was expressed in scanning units representing the scanning area under the curve, which is an integration ratio that takes into account both brightness and width of the substrate lysis zone. Second, the gelatinolytic activity that resulted from the balance between enzymes and enzyme inhibitors (the so-called protease load) was measured in the samples usinḡ uorescence-activated gelatin conversion. Both methods have been described in detail previously w15, 39, 40x.
Statistical analysis
Statistical analysis was performed using the Mann± Whitney method to analyse differences in PG-induced proliferation and the production of effector molecules between RA patients and healthy subjects. The Wilcoxon signed rank test method was used to determine whether PG was able to induce cytokine production. Linear regression was performed to determine relationships of disease activity and disease duration with T-cell proliferation and cytokine production. P values < 0.05 were considered signi®cant.
Results
Proliferation of PBMC after stimulation with PG
To examine whether proliferation of T cells in response to PG was increased in RA patients compared with healthy subjects, 29 RA patients and 33 age-matched controls were examined for the proliferative response, to PG spleen and PG-PS faeces . LPS and TT were used as positive controls. The results show (Fig. 1 ) that, after 7 days of culture, T-cell proliferation was elicited by PG spleen in 21 of the 29 RA patients. In 33 healthy donors, 25 reacted against PG spleen . The median SI value was 6.9 for RA patients and 6.7 for healthy subjects. The proliferative response to PG-PS faeces was lower than that to PG spleen despite the 100-fold higher concentration used. The proliferative responses to LPS and TT were lower in RA patients than in healthy donors, but this difference did not reach signi®cance.
Proliferation of SFMC after stimulation with PG Synovial¯uid was obtained from 14 RA patients. Mononuclear cells were isolated from both samples using Ficoll. In only two of the synovial¯uid samples could a proliferative response to PG spleen be measured (Fig. 2) . After stimulation with PG-PS faeces , LPS and TT, the number of patients responding was 0, 3 and 2 out of 14 respectively. When the proliferative responses of 10 samples of synovial¯uid mononuclear cells of the four analysed antigens were compared with those of paired peripheral blood cells, responses were signi®cantly lower despite the use of identical cell numbers and stimulation conditions (data not shown).
Relationships of proliferation with disease activity and disease duration Correlation analysis was performed to determine the possible relationships between proliferation and RA disease activity or disease duration as scored at the time of sampling. No correlations were found for any of the four antigens examined.
Cytokine production in peripheral blood after stimulation with PG spleen To investigate whether PG is able to stimulate production of the cytokines involved in RA, the production of IL-1b, IL-6, IL-8, IL-10, IL-12, IFN-c and TNF-a was measured after whole-blood cell stimulation of 20 RA Fig. 3 . These results show that, without stimulation, concentrations of all analysed cytokines were higher for RA patients than for healthy subjects. Because this higher concentration was mostly due to ®ve to seven highresponding patients, the difference between control subjects and RA patients was only signi®cant for IL-10.
In healthy subjects, PG spleen -induced production of IL-1b, IL-6, IL-8, IL-10, IL-12 and TNF-a was signi®cantly increased compared with spontaneous production. In the RA patients a signi®cant increase in the production of IL-1b, IL-6, IL-8, IL-10 and TNF-a was observed.
Because cytokine levels in unstimulated samples of RA patients were very high, probably due to cytokines already present in the plasma, mononuclear cells were isolated to measure newly secreted cytokine. Table 2 shows that, after control stimulation with medium alone, all cytokine levels were low except IL-8. After PG stimulation a signi®cant increase was observed for all cytokines except IL-12 and IFN-c. After stimulation with LPS, similar results were observed (data not shown).
Cytokine production in synovial¯uid after stimulation with PG spleen Cytokine production was induced and measured in supernatants of whole synovial¯uid mononuclear cells and of isolated mononuclear cells from nine RA patients. The results show that all cytokines analysed were present in the synovial¯uid. After stimulation with PG, the production of IL-1b, IL-6, IL-8 and TNF-a was increased (Table 3) .
When mononuclear cells were isolated, high concentrations of IL-6, IL-8 and TNF-a were measured without further stimulation, indicating that activated mononuclear cells produced these cytokines spontaneously. After PG stimulation, IL-1b, IL-8, IL-10 and TNF-a were produced at signi®cantly higher levels, indicating that PG can increase the production of these cytokines in SFMC.
For nine patients, paired samples of peripheral blood and synovial¯uid were analysed. Concentrations of the different cytokines in unstimulated samples were similar in peripheral blood and synovial¯uid except for IL-10, IFN-c and IL-12, for which concentrations were higher in synovial¯uid than in peripheral blood; however, these differences were not signi®cant (data not shown). After stimulation with LPS, similar results were observed (data not shown).
Gelatinase B production in whole blood and synovial¯uid after stimulation with PG spleen Quantitative analysis of gelatinase B production showed that, in blood cells, gelatinase B concentration was higher, although not signi®cantly, so in RA patients than in healthy subjects, suggesting a higher spontaneous release of gelatinase B in the peripheral blood of RA patients (Fig. 3) . Furthermore, it was shown that PG induces production of gelatinase B. In blood samples of healthy subjects this induction was signi®cant (Fig. 3) . In synovial¯uid samples the induction of gelatinase B by PG did not reach signi®cance (Table 3) . Analysis of the kinetics of the dose-dependent induction of gelatinase B by PG showed that gelatinase B was induced after 4 h of incubation (data not shown). To determine whether this induction resulted in an increase in gelatinase activity, all samples were also analysed bȳ uorescence activated substrate conversion. None of these samples showed net gelatinase B activity.
Relationships of cytokine production with disease activity and disease duration To examine the possible relationships between (PGinduced) cytokine and gelatinase production and RA pathology, linear regression was performed for cytokine production separately both for peripheral blood and synovial¯uid and for disease activity and disease duration. Although cytokine production by unstimulated cells showed a positive relationship with disease activity in both blood and synovial¯uid samples with most cytokines, in particular with IL-6 and TNF-a, no signi®cant correlation was observed (data not shown).
Discussion
The present study shows that PG fractionated from sterile human spleen is able to induce T-cell proliferation in peripheral blood and synovial¯uid of RA patients, and that PG is able to induce production of the in¯ammatory mediators IL-1b, IL-6, IL-8, IL-10 and TNF-a as well as gelatinase B in peripheral blood and synovial¯uid cells. No differences were observed between the T-cell proliferation and cytokine production induced by PG in RA patients and healthy subjects.
In about 75% of RA patients and control donors, proliferation of PBMC against PG was observed. This indicates that there is no apparent disturbance of speci®c T-cell proliferation in response to PG in RA patients compared with healthy donors. The lower proliferative response against PG-PS faeces in both groups, even with a 100-fold higher concentration, supports the importance of intact PG structure in the induction of T-cell proliferation, because PG spleen contains intact peptide bridges, which are almost absent in PG-PS faeces . There is also no indication that, at the site of in¯am-mation, proliferation after stimulation with PG contributes to pathogenesis, because proliferation was observed in only two of the 14 RA patients analysed. Because T-cell proliferation in synovial¯uid mononuclear cells is very low after stimulation with the positive control stimuli LPS and TT, it is possible that the method used was not optimal. The mean ratio of APC (i.e. monocytesumacrophages) to T cells was 1 : 1.4 in the synovial¯uid, as shown by morphology analysis of cytospins of the synovial¯uid cells (data not shown). FIG. 3 . PG spleen induces cytokine production in healthy subjects and RA patients. Whole blood cell samples of 20 RA patients and 10 healthy controls were stimulated or not stimulated with PG spleen . Production of IL-1b, IL-6, IL-8, IL-10, IL-12, TNF-a, and IFN-c was assessed by ELISA. Levels of all cytokines were higher in unstimulated samples of RA patients compared with healthy controls; the difference was signi®cant for IL-10. PG spleen was signi®cantly induced production of IL-1b, IL-6, IL-8, IL-10 and TFN-a in both healthy subjects and RA patients. IL-12 was signi®cantly induced only in healthy subjects.
In peripheral blood this ratio was approximately 1 : 5, implying that many more potentially responsive T cells were present in the wells. Another explanation for the lack of synovial¯uid T-cell proliferation is that most synovial¯uid T cells, despite the expression of CD45RO, are hyporesponsive upon stimulation by anti-CD3 and anti-CD28 w41x. A defect in T-cell receptormediated signalling at the level of tyrosine phosphorylation has been suggested w42x.
Cytokine induction by PG was measured using two different cell populations: whole blood or synovial cells and isolated mononuclear cells. The whole blood cell culture technique has proved to be quite reproducible w43±45x and it closely re¯ects the in vivo situation. However, because in some RA patients the cytokine concentrations present in unstimulated samples were very high, further stimulation of cytokine production by PG was dif®cult to examine. Therefore, we also used Ficoll-puri®ed mononuclear cells to measure newly secreted cytokines, and cytokines already present in the plasma were not measured.
Both in blood and synovial¯uid of RA patients, higher levels of IL-6, IL-8, IL-10, IL-12, IFN-c and TNF-a were present in unstimulated samples compared with healthy subjects. This is consistent with earlier reports w11, 46, 47x. Production of IL-1b, IL-6, IL-8, IL-10 and TNF-a was increased after PG spleen stimulation in both healthy donors and RA patients by cells in peripheral blood and synovial¯uid. An increase in IL-12 after induction by PG spleen was only found in whole blood cell stimulations of healthy subjects. No production of IFN-c induced by PG spleen could be demonstrated. This is not surprising as IFN-c is produced mainly by T cells, and T-cell stimulation by PG spleen reached its highest level after 7 days of culture instead of 17 h. In accordance with this, cytokine production measured in PBMC stimulations of healthy donors at day 7 showed that high amounts of IFN-c (137±399 nguml) were produced, but no IL-4 (data not shown). In two out of 14 synovial¯uid samples, no induction of TNF-a, IL-6 and IL-1 could be observed. The cells of these patients were also refractory to stimulation with PG of LPS. In one patient, this might have been a result of the use of steroids. The use of prednisone and methotrexate by some of the patients also resulted in lower cytokine production by the blood cells compared with patients not using these drugs, but these differences were not signi®cant.
Gelatinase B is detected in synovial¯uid w15x and is expressed in the synovial tissues of RA patients w48, 49x, where it plays an important role in connective tissue destruction by degrading components of the extracellular matrix w50x. This study shows that PG spleen is able to induce production of this enzyme. Whether this enzyme is induced directly or indirectly through IL-8 or TNF-a for example, which are known to induce gelatinase B w15, 51, 52x, has to be analysed further using speci®c antibodies. The kinetic analysis of gelatinase B expression is in favour, however, of a direct effect of PG. The lack of net gelatinase B activity in the samples can be explained by the presence of natural and possibly induced inhibitors of gelatinase B activity w53x.
To determine if the biological properties of PG are directly involved in the pathogenesis of RA, possible relationships of cellular proliferation and cytokineu gelatinase B production with disease activity and disease duration was analysed using correlation analysis. For most cytokines there was a trend for higher cytokine production to be positively related to disease activity Data are median cytokine production (pguml) and median gelatinase B production (scanning units) with range in parentheses. n.d. = not done. *P < 0.05.
and negatively related to disease duration. These trends did not reach signi®cance.
There remains the question of what role PG plays in the pathogenesis of RA. The main indication for a role of PG in RA is the presence of PG in APC in synovial tissues w32x, suggesting that bacterial antigens, ubiquitously present in this mucosa, gain access to the joints, probably carried by phagocytic APC in the bloodstream w54x. The distribution of PG might be increased by ultrastructural gut lesions w55x or a reduced level of protection of the mucosal surface provided by antibodies against PG w56x. Although this study did not identify disturbances in the T-cell response against PG, the results do show that PG is able to induce production of effector molecules that are crucially involved in RA. On the basis of these results, we hypothesize that PG is involved in the pathogenesis of RA by inducing cytokines and gelatinase B. First, the production of these cytokines and gelatinase B can lead to destruction of the joint tissue. Secondly, cytokines might allow autoreactive T cells to overcome self-tolerance to certain autoantigens. Recent studies have shown that various infectious and proin¯ammatory agents, such as LPS, a functional PG analogue, are capable of reversing the tolerant state of CD4 + w57x and CD8 + w58x T cells in the presence of speci®c (auto)antigens by the production of cytokines stimulating T-cell proliferation and survival w59, 60x. Thus, in¯ammatory activity within the RA joint may be dependent on factors governing the redistribution of PG to non-mucosal sites. Therapeutic intervention restricting the access of PG to non-mucosal sites may therefore be of clinical bene®t to patients. This can be examined using in vivo bacterial translocation models.
